FDA Clearance Tracker · K231283
SiteRite 9 Ultrasound System
Last checked: Nov 19, 2026Latest source record: Sep 11, 2023 (this decision)Source: openFDAMethods & limitations
Decided
Sep 11, 2023
Substantially Equivalent
Time to decision
131 days
Received May 3, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K231283
- Device name
- SiteRite 9 Ultrasound System
- Applicant location
- Salt Lake Ciy,, UT
- Received
- May 3, 2023
- Decided
- Sep 11, 2023
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 892.1560
- Specialty
- Radiology & Imaging
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code IYO. The earliest in FDA's data is K771290, decided Aug 3, 1977.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K231283
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Bard Access Systems, Inc. (C.R. Bard, Inc.)
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K233106 · Decided Apr 19, 2024 · 205 days after receipt
Device type: Catheter, Intravascular, Therapeutic, Short-Term Less Than 30 Days (FOZ) · Hospital Medicine & Nursing
K211193 · Decided Jun 25, 2021 · 65 days after receipt
Device type: System, Imaging, Pulsed Echo, Ultrasonic (IYO) · Radiology & Imaging
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.